JPS6156659A - Immobilization of biologically active substance - Google Patents
Immobilization of biologically active substanceInfo
- Publication number
- JPS6156659A JPS6156659A JP59169030A JP16903084A JPS6156659A JP S6156659 A JPS6156659 A JP S6156659A JP 59169030 A JP59169030 A JP 59169030A JP 16903084 A JP16903084 A JP 16903084A JP S6156659 A JPS6156659 A JP S6156659A
- Authority
- JP
- Japan
- Prior art keywords
- biologically active
- active substance
- immobilizing
- immobilization
- plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、生物活性物質の固定化方法に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to a method for immobilizing biologically active substances.
更に詳しくは、酵素、微生物などの生物活性物質をフッ
素樹脂成形品、ガラスβに珍品′f、【どの生物活性物
質固定化材の表面に固定化する方法に関する。More specifically, the present invention relates to a method for immobilizing biologically active substances such as enzymes and microorganisms on the surface of fluororesin molded articles, glass β, and other biologically active substance immobilizing materials.
従来から酵素、微生物などの生物活性物質全種々の材料
上に固定化し、例えばバイオセンサー用膜、アフイニテ
イクロマトグラフイー、バイオリアクターなどの用途に
用いることか行わrしている。BACKGROUND ART Biologically active substances such as enzymes and microorganisms have been immobilized on various materials and used for applications such as biosensor membranes, affinity chromatography, and bioreactors.
一方、やはり従来から人工血管、カテーテル、人工臓器
などの材料として用いられているポリテトラフルオロエ
チレンなどのフッ素樹脂の成ル品に、例えばウロキナー
ゼ酵素を固定すれば、生体材料の問題点となっている抗
血栓性の舟注?付与することができるなどの効果が期待
さオする。On the other hand, for example, if urokinase enzyme is immobilized on a manufactured product of fluororesin such as polytetrafluoroethylene, which has traditionally been used as a material for artificial blood vessels, catheters, and artificial organs, problems with biomaterials may arise. Is there an antithrombotic drug? It is expected that the effects such as the following can be achieved.
即ぢ、耐熱性、耐薬品性、酸素透過性などの性質ですぐ
れた特性を示すフッ素′1fJJ脂成彰品に、生物学的
特性を更に付加させることができれば、それの応用@凹
は質的にもまた琶的にも飛躍的に拡大できることが期待
される。In other words, if it is possible to add biological properties to fluorine 1fJJ resin products, which have excellent properties such as heat resistance, chemical resistance, and oxygen permeability, its application would be qualitative. It is expected that the company will be able to expand dramatically both in Japan and in Japan.
また、ガラス成形品は、生物活性物質の固定化材の代表
的なものとして従来から用いられており、特にそれの球
状のものはバイオリアクターなどとして有効に使用され
ているので、そこに生物活性物質を更に効果的に結合さ
せることができれば、その有用性は一層高められること
になる。In addition, glass molded products have traditionally been used as a typical immobilization material for biologically active substances, and spherical ones in particular are effectively used in bioreactors, etc. If substances can be combined more effectively, their usefulness will be further enhanced.
こうした各種の用途に供するために、生物活性物質固定
化材としてのフッ素樹脂成形品上に生物活性物質を固定
化せ[7める方法としては、成形品表面ケ金属カリウム
でエツチングして不飽和結合を形成させ、そこに生物活
性物質との結合性を有する単凰体を結合させる方法ある
いは物理的吸着方法などが用いられている。また、ガラ
ス板上に1 生物活性物質を固定イけしめる方法と
し′Cは・′ランカップリング剤を用いる方法あるいは
物理的吸着方法などが用いられている。しかしながら、
金属カリウム、シランカップリング剤を用いる方法は、
工程的に煩雑であるばかりではなく、特に前者では危険
性が大であり、また物理的吸着方法ではその結合力に不
安がみられる。In order to provide these various uses, biologically active substances are immobilized on fluororesin molded products as biologically active substance immobilizing materials [7] One way to immobilize biologically active substances is to etch the surface of the molded product with potassium metal to make it unsaturated. A method of forming a bond and attaching a single phosphor having a binding property to a biologically active substance to the bond, or a physical adsorption method, etc. are used. In addition, as a method of immobilizing a biologically active substance on a glass plate, a method using a 'C--' run coupling agent or a physical adsorption method is used. however,
The method using metallic potassium and a silane coupling agent is
Not only is the process complicated, but the former is particularly dangerous, and physical adsorption methods have concerns about their binding strength.
かかる現状に鑑み、本発明者は元来生物活性物質を固定
させ難いそれの固定化材上に生物活性物質を容易かつ強
固に結合させ得る方法について種々検討の結果、生物活
性物質固定化材の表面に、生物活性物質のアミ7基と結
合し得る化合物であるアルデヒド化合物またはイソシア
ネート化合物をプラズマ重合させるごとにより、かかる
課題が有効に解決し得ることを見出した。In view of the current situation, the present inventor has conducted various studies on methods for easily and firmly bonding biologically active substances to immobilizing materials, which are difficult to immobilize biologically active substances on. It has been found that this problem can be effectively solved by plasma polymerizing an aldehyde compound or an isocyanate compound, which is a compound capable of bonding with the amide 7 group of a biologically active substance, on the surface.
〔問題点を解決するための手段〕および〔作用〕従って
、本発明は生物活性物質の固定化方法に係り、生物活性
物質の固定化は、生物活性物質固定化材の表面にアルデ
ヒド化合物またはイソシアネート化合物をプラズマ重合
させ、次いでそこに生物活性物質を結合させることによ
り行わね、る。[Means for Solving the Problem] and [Operation] Accordingly, the present invention relates to a method for immobilizing a biologically active substance, and the immobilization of a biologically active substance is performed by applying an aldehyde compound or an isocyanate to the surface of a biologically active substance immobilizing material. This is done by plasma polymerizing the compound and then attaching the biologically active substance thereto.
プラズマ重合処理は、例えば第1図にその概要が示され
るような装置を用いて行われる。即ち、真空ポンプ1、
リークパルプ2およびメインバルブ3に接続され、真空
計4t−備えたプラズマ反応容器5内に、例えばポリテ
トラフルオロエチレン樹脂膜またはガラス板6を収容し
、反応容器内の圧力を約0.001〜IQ Torrと
した後パルプ7を開き、反応容器内にタンク8からのア
ルデヒド化合物またはイソシアネート化合物を導入する
。これらの化合物を等大している状態で、高周波発生装
R(13,56MHz ) 9およびマツチングユニッ
ト10からなる高周波電源を用いて、有効電力約50〜
200w、時間約5〜600秒間の条件下で、発振コイ
ル11からプラズマ照射する。反応容器としては、チュ
ーブ状およびペルジャー型のいずれをも用、いることが
でき、また放@電極としては、コイル状のもの以外に、
外部もしくは内部平行電極板を用いることもできる。The plasma polymerization treatment is carried out using, for example, an apparatus as schematically shown in FIG. That is, the vacuum pump 1,
For example, a polytetrafluoroethylene resin membrane or a glass plate 6 is housed in a plasma reaction vessel 5 connected to the leak pulp 2 and the main valve 3 and equipped with a vacuum gauge 4t, and the pressure inside the reaction vessel is maintained at about 0.001 to After setting the IQ Torr, the pulp 7 is opened and the aldehyde compound or isocyanate compound from the tank 8 is introduced into the reaction vessel. With these compounds being equal in size, using a high frequency power source consisting of a high frequency generator R (13,56 MHz) 9 and a matching unit 10, an effective power of about 50 ~
Plasma is irradiated from the oscillation coil 11 under conditions of 200 W and a time of about 5 to 600 seconds. As a reaction vessel, either a tube-shaped or a Pelger type can be used, and as a discharge electrode, in addition to a coil-shaped one,
External or internal parallel electrode plates can also be used.
前述の如く、生物活性物質固定化材としては、ポリテト
ラフルオロエチレン樹脂成形品、ガラス成形品などが好
んで用いられ、その形状も板状体、膜状体、球状体、繊
維状体など任意の形態をとり得る。As mentioned above, polytetrafluoroethylene resin molded products, glass molded products, etc. are preferably used as biologically active substance immobilization materials, and the shapes can be arbitrary such as plate-like, membrane-like, spherical, and fibrous. It can take the form of
これらの固定化材の表面にプラズマ重合させるアルデヒ
ド化合物としては、例えばグルタルアルデヒド、ホルム
アルデヒド、アセトアルデヒドなどが、またイソシアネ
ート化合物としては、例えばトルエンジイソシアネート
、イソホロンジイソシアネート、ヘキサメチレンジイソ
シアネートなどがそれぞれ挙げられる。これらの重合性
単皿体化合物は、そのままの状態であるいは水溶液など
の状態で用いられ、中には沸点の高い化合物もみられる
が、前記した如きプラズマ反応容器内の減圧度によって
、また更に約40〜1oo℃に適宜加熱することによっ
て、気体状となってプラズマ反応に供せられる。Examples of the aldehyde compounds to be plasma-polymerized on the surface of these immobilizing materials include glutaraldehyde, formaldehyde, acetaldehyde, etc., and examples of the isocyanate compounds include toluene diisocyanate, isophorone diisocyanate, hexamethylene diisocyanate, and the like. These polymerizable single-plate compounds are used as they are or in the form of an aqueous solution, and some of them have high boiling points, but depending on the degree of vacuum in the plasma reaction vessel as described above, By appropriately heating it to ~100° C., it becomes gaseous and is subjected to a plasma reaction.
このようなプラズマ重金属に結合される生物活性物質と
しては、酵素、微生物などが挙げられ、例えば酵素の場
合には一般に約0.1〜10m9/−の水溶液として用
いられる。Such biologically active substances bound to plasma heavy metals include enzymes, microorganisms, etc. For example, in the case of enzymes, they are generally used as an aqueous solution of about 0.1 to 10 m<9>/-.
酵素としては、例えばグルツースオキシダーゼ、アミノ
酸オキシダーゼ、コレステロールオキシダ−七、ウリカ
ーゼなどのオキシダーゼ類、ウリアーゼ、フレアキニナ
ーゼ、グルタミナーゼ、べ二シリナーゼ、カタラーゼ、
パーオキシダーゼ、インベルターゼ、ムタロターゼ、ア
ミラーゼ、パパイン、トリプシンなどのプロテアーゼ類
、グルコースイソメラーゼ、ウロキナーゼなどが挙げら
れる。また、微生物としては、例えばシュードモナス・
フルオレッセンス、バチルス・ズブチリス、シュードモ
ナス・エルギノーザなどの細菌類、アスペルギルス・ニ
ガー、リゾプス・ホルモ、センシスなどの糸状菌類、ス
トレプトミセス・グリセウスなどの放線菌類、酵母菌、
かびなどが挙げられる。この他に、その構造中にアミン
基を有するたん白質などの生物学的活性を有する他の物
質にも、本発明方法は適用される。Examples of enzymes include oxidases such as glutenose oxidase, amino acid oxidase, cholesterol oxidase 7, and uricase, uriase, flakininase, glutaminase, benicillinase, catalase,
Examples include proteases such as peroxidase, invertase, mutarotase, amylase, papain, and trypsin, glucose isomerase, and urokinase. In addition, examples of microorganisms include Pseudomonas
Bacteria such as Bacillus fluorescens, Bacillus subtilis, and Pseudomonas aeruginosa, filamentous fungi such as Aspergillus niger, Rhizopus hormo, and Sensis, actinomycetes such as Streptomyces griseus, yeast,
Examples include mold. In addition, the method of the present invention can also be applied to other biologically active substances such as proteins having amine groups in their structures.
1 本発明方法により生物活性物質をフッ素樹脂成形
品、ガラス成形品などの固定化材、特にガラス成形品の
表面に固定化せしめたものは、その固定化が容易かつ強
固に行われるばかりではなく、固定化材の特性が更に加
味されるので、人工血管、縫合糸などの医用材料、バイ
オリアクター、バイオセンサーなどの用途にいずれも有
効に使用することができる。1. The method of the present invention in which biologically active substances are immobilized on the surface of fluororesin molded products, glass molded products, etc., especially on the surface of glass molded products, not only can the immobilization be easily and firmly carried out, but also Since the properties of the immobilization material are further taken into account, it can be effectively used for applications such as artificial blood vessels, medical materials such as sutures, bioreactors, and biosensors.
次に、実施例について本発明を説明する。 Next, the present invention will be explained with reference to examples.
実施例1〜4
図示された態様に従って、プラズマ取合が行わレタ。固
定化材としては、ポリテトラフルオロエチレン樹脂(p
ryx+)tfCはガラスからそれぞれ成形された10
X 10 X 0.5 mの大きさのものが用いられ
、反応容器内の圧力をQ、QI Torrとした後、0
.5−の水溶液から気化させたプラズマ数合性単n体を
導入し、13.56 MHzの高周波発生装置を用いて
、有効電力150W、時間10分間の条件下でプラズマ
照射を行ない、重合反応させた。Examples 1-4 Plasma interaction was carried out according to the illustrated embodiment. As the immobilizing material, polytetrafluoroethylene resin (p
ryx+)tfC are each molded from glass.
A reactor with a size of X 10 X 0.5 m was used, and after setting the pressure inside the reaction vessel to Q
.. Introducing the plasma combinable single n substance vaporized from the aqueous solution of 5-, using a 13.56 MHz high frequency generator, plasma irradiation was performed under conditions of an effective power of 150 W and a time of 10 minutes to cause a polymerization reaction. Ta.
照射終了後、反応容器中から表面にプラズマ重合層を形
成させた固定化材を取り出し、これを酵素濃度1 my
/mlの枯草菌起源アルカリプロテアーゼ(長瀬産業販
売品、酵素番号に、0.3.4.4.16 )の4’℃
の水溶液中に24時間浸漬した。その後、100ゴの蒸
留水で洗浄した。After the irradiation, the immobilization material with a plasma polymerized layer formed on its surface was taken out from the reaction vessel and was heated to an enzyme concentration of 1 my
/ml of Bacillus subtilis-derived alkaline protease (product sold by Nagase Sangyo, enzyme number: 0.3.4.4.16) at 4'°C.
It was immersed in an aqueous solution for 24 hours. Thereafter, it was washed with 100 g of distilled water.
得られた固定化#素の活性が、カゼイン基質を用い、ア
ンソン−荻原氏変法によって測定された。The activity of the obtained immobilized #element was measured by a modified Anson-Ogiwara method using a casein substrate.
測定条件は、酢酸緩衝液中、pH7,5、温度35℃、
紫外線吸収波長660 nmである。また、固定化酵素
を、4℃の酢酸緩衝液5−中に24時間浸漬した後、同
様に酵素活性を測定することにより、固定化酵素の脱雅
の有無が判定された。得られた結果は、次の表に示され
る。The measurement conditions were: in acetate buffer, pH 7.5, temperature 35°C;
The ultraviolet absorption wavelength is 660 nm. In addition, the presence or absence of degeneration of the immobilized enzyme was determined by immersing the immobilized enzyme in acetate buffer solution 5 at 4° C. for 24 hours and then measuring the enzyme activity in the same manner. The results obtained are shown in the following table.
表
同濃度C%) 50 25
50 25酵素尚コmTJ/2j) 3
゜4 3.0 9.5 5
.0脱離酵素 なし なし なし
なしTable same concentration C%) 50 25
50 25 Enzyme Naoko mTJ/2j) 3
゜4 3.0 9.5 5
.. 0-eliminating enzyme None None None None
第1図は 本発明で用いられるプラズマ重合装置の一態
様を示す概略図である。
(符号の説明)
l・・・・・・真空ポンプ
5・・・・・・プラズマ反応容器
6・・・・・・生物活性物質固定化材
9・・・・・・高周波発生装置
11・・・・・・発振コイルFIG. 1 is a schematic diagram showing one embodiment of a plasma polymerization apparatus used in the present invention. (Explanation of symbols) l...Vacuum pump 5...Plasma reaction vessel 6...Bioactive substance immobilization material 9...High frequency generator 11... ...oscillation coil
Claims (1)
たはイソシアネート化合物をプラズマ重合させ、次いで
そこに生物活性物質を結合させることを特徴とする生物
活性物質の固定化方法。 2、生物活性物質固定化材がフッ素樹脂成形品である特
許請求の範囲第1項記載の生物活性物質の固定化方法。 3、フッ素樹脂成形品がポリテトラフルオロエチレン樹
脂成形品である特許請求の範囲第2項記載の生物活性物
質の固定化方法。 4、生物活性物質固定化材がガラス成形品である特許請
求の範囲第1項記載の生物活性物質の固定化方法。 5、生物活性物質が酵素である特許請求の範囲第1項記
載の生物活性物質の固定化方法。 6、生物活性物質が微生物である特許請求の範囲第1項
記載の生物活性物質の画定化方法。[Scope of Claims] 1. A method for immobilizing a biologically active substance, which comprises plasma polymerizing an aldehyde compound or an isocyanate compound on the surface of a biologically active substance immobilizing material, and then bonding the biologically active substance thereto. 2. The method for immobilizing a biologically active substance according to claim 1, wherein the biologically active substance immobilizing material is a fluororesin molded article. 3. The method for immobilizing a biologically active substance according to claim 2, wherein the fluororesin molded product is a polytetrafluoroethylene resin molded product. 4. The method for immobilizing a biologically active substance according to claim 1, wherein the biologically active substance immobilizing material is a glass molded article. 5. The method for immobilizing a biologically active substance according to claim 1, wherein the biologically active substance is an enzyme. 6. The method for defining a biologically active substance according to claim 1, wherein the biologically active substance is a microorganism.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59169030A JPS6156659A (en) | 1984-08-13 | 1984-08-13 | Immobilization of biologically active substance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59169030A JPS6156659A (en) | 1984-08-13 | 1984-08-13 | Immobilization of biologically active substance |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6156659A true JPS6156659A (en) | 1986-03-22 |
JPH0575430B2 JPH0575430B2 (en) | 1993-10-20 |
Family
ID=15879016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59169030A Granted JPS6156659A (en) | 1984-08-13 | 1984-08-13 | Immobilization of biologically active substance |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6156659A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5552755A (en) * | 1978-10-12 | 1980-04-17 | Sumitomo Electric Industries | Tubular internal organ prosthetic material and its preparation |
JPS5552754A (en) * | 1978-10-12 | 1980-04-17 | Sumitomo Electric Industries | Tubular internal organ prosthetic material and its preparation |
JPS5588760A (en) * | 1979-10-25 | 1980-07-04 | Hiroshi Matsumoto | Artificial blood vessel |
-
1984
- 1984-08-13 JP JP59169030A patent/JPS6156659A/en active Granted
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5552755A (en) * | 1978-10-12 | 1980-04-17 | Sumitomo Electric Industries | Tubular internal organ prosthetic material and its preparation |
JPS5552754A (en) * | 1978-10-12 | 1980-04-17 | Sumitomo Electric Industries | Tubular internal organ prosthetic material and its preparation |
JPS5588760A (en) * | 1979-10-25 | 1980-07-04 | Hiroshi Matsumoto | Artificial blood vessel |
Also Published As
Publication number | Publication date |
---|---|
JPH0575430B2 (en) | 1993-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4004979A (en) | Preparation of active proteins cross-linked to inactive proteins | |
US4378435A (en) | Process for providing enzyme activity to a solid surface | |
Fernandez-Lorente et al. | Immobilization of proteins on highly activated glyoxyl supports: Dramatic increase of the enzyme stability via multipoint immobilization on pre-existing carriers | |
Park et al. | Covalent immobilization of GL-7-ACA acylase on silica gel through silanization | |
US4268419A (en) | Support matrices for immobilized enzymes | |
Marconi | Immobilized enzymes: their catalytic behaviour and their industrial and analytical applications | |
JPS6156659A (en) | Immobilization of biologically active substance | |
JPH01240188A (en) | Functional organic thin film | |
JPH0318877B2 (en) | ||
JPH0223868A (en) | Production of carrier for immobilizing physiologically active substance | |
JPS6157628A (en) | Production of physiologically active substance immobilized film | |
JPS63304000A (en) | Method for immobilizing substance derived from living body | |
JPS6187699A (en) | Method of immobilizing physiologically active substance | |
Wang et al. | Immobilization of α-amylase from Bacillus licheniformis on developed support using microbial transglutaminase | |
JP2778048B2 (en) | Method for producing carrier for immobilizing biological material | |
JP2504087B2 (en) | Method for producing a carrier for immobilizing a physiologically active substance | |
GB1560691A (en) | Enzyme membrane | |
JPH0320233B2 (en) | ||
JPS61187792A (en) | Production of immobilized living body catalyst | |
JPH0453490A (en) | Carrier supporting immobilized physiologically active substance and production thereof | |
JPS6232884A (en) | Immobilization of physiologically active substance | |
JPS63230078A (en) | Biosensor and production thereof | |
JPS6134796B2 (en) | ||
JPS6115900A (en) | Porous membrane of modified cellulose | |
JPH01102352A (en) | Biosensor |